0001628280-20-017744.txt : 20201223 0001628280-20-017744.hdr.sgml : 20201223 20201223182410 ACCESSION NUMBER: 0001628280-20-017744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans Richard B. Jr. CENTRAL INDEX KEY: 0001632641 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34746 FILM NUMBER: 201413896 MAIL ADDRESS: STREET 1: C/O ACCRETIVE HEALTH, INC. STREET 2: 401 N. MICHIGAN AVENUE, SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: R1 RCM INC. CENTRAL INDEX KEY: 0001472595 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 020698101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-324-7820 MAIL ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Accretive Health, Inc. DATE OF NAME CHANGE: 20090918 4 1 wf-form4_160876583729288.xml FORM 4 X0306 4 2020-12-22 0 0001472595 R1 RCM INC. RCM 0001632641 Evans Richard B. Jr. C/O R1 RCM INC. 401 N. MICHIGAN AVE, SUITE 2700 CHICAGO IL 60611 0 1 0 0 Principal Accounting Officer Common Stock 2020-12-22 4 M 0 17743 0 A 73862 D Common Stock 2020-12-22 4 M 0 185956 0 A 259818 D Common Stock 2020-12-22 4 F 0 88275 23.43 D 171543 D Performance-Based Restricted Stock Units 2020-12-22 4 M 0 17743 0 D Common Stock 17743.0 0 D Performance-Based Restricted Stock Units 2020-12-22 4 M 0 185956 0 D Common Stock 185956.0 0 D Represents shares of common stock received upon settlement of performance-based restricted stock units ("PBRSUs"). 25% of the amount represents shares earned upon settlement of the PBRSUs, which remain subject to continued service by the reporting person through December 31, 2021. Refer to footnote 4 for further details. Represents a contingent right to receive the Issuer's common stock. On May 29, 2018, the reporting person was granted PBRSUs that were previously reported on Table II of Form 4 filed on May 31, 2018. Pursuant to the award agreement, the PBRSUs were subject to both a time-based vesting condition and a performance-based vesting condition based on an average per share price of the Issuer's common stock as defined in the award agreement, measured at December 22, 2020. At target, the PBRSUs covered 11,829 shares. Because the average price per share at the end of the performance period exceeded the maximum target of $14.00 per share, the reporting person earned the maximum number of shares, or 150% of the target award. The time-based vesting condition for 75% of the PBRSUs was satisfied on December 22, 2020. The time-based vesting condition for the remaining 25% of the PBRSUs may be satisfied on the earlier of December 31, 2021 and a qualifying change of control. On August 28, 2017, the reporting person was granted PBRSUs that were previously reported on Table II of Form 4 filed on November 21, 2017. Pursuant to the award agreement, the PBRSUs were subject to both a time-based vesting condition and a performance-based vesting condition based upon an average per share price of the Issuer's common stock as defined in the award agreement, measured at December 22, 2020. At target, the PBRSUs covered 92,978 shares. Because the average price per share at the end of the performance period exceeded the maximum target of $9.00 per share, the reporting person earned the maximum number of shares, or 200% of the target award. The time-based vesting condition was fully satisfied on December 22, 2020. /s/ E. Terry Platis, Attorney-in-Fact 2020-12-23